Long-term efficiacy of intrathecal opioid therapy

Long-term efficiacy of intrathecal opioid therapy - IOT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00014019

Enrollment

Registered

2018-02-13

Start date

2016-05-26

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic pain patients carrying an intrathecal opioid pump/ efficiacy of the therapy and unwanted side-effects of the intrathecal opioid therapy R52.2

Interventions

Group 1: retrospective data collection from the patients charts: age, gender, duration of anamnesis, diagnosis, complications of intrathecal opioid therapy, revision operations, intrathecal opioid d

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: intrathecal opioid application via medication pump for at least five years ability to understand and fill in the questionnaire

Exclusion criteria

Exclusion criteria: severe psychiatric comorbidity (i.e. severe depression) linguistic or cognitive incapacity to fill in the questionnaire

Design outcomes

Primary

Measure	Time frame
pain rating on the NRS, recorded from the patients charts and from the questionnaire	—

Secondary

Measure	Time frame
side-effects of the intrathecal opioid therapy and further pain-relevant parameters such as life quality, anxiety/depression, sleep, quality and satisfaction with intrathecal opioid therapy, recorded from the questionnaire	—

Countries

Germany

Contacts

Public ContactTilman Wolter

Interdisziplinäres Schmerzzentrum, UKL Freiburg

tilman.wolter@uniklinik-freiburg.de0761/27054810

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026